Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Themis Biosyn Limited has filed copies of newspaper advertisements publishing its unaudited financial results for the quarter ended June 30, 2025, in Western Times (English and Gujarati editions) on August 2, 2025. The filing is a routine regulatory submission under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements. The underlying results, already approved by the Board on August 1, 2025, show total income from operations of Rs. 3,614.72 lakhs, down about 8% year-on-year from Rs. 3,935.17 lakhs. Net profit after tax came in at Rs. 906.16 lakhs, a steep drop of roughly 31.5% from Rs. 1,323.62 lakhs in the same quarter last year. Basic EPS for the quarter stood at Rs. 0.83 versus Rs. 1.21 in Q1 FY25. The company operates in a single segment — manufacturing of bulk drugs.
This is a procedural newspaper-publication filing rather than new information, as the Q1 numbers were already disclosed earlier. However, the underlying results point to a significant year-on-year decline in both revenue and profits, which could weigh on near-term investor sentiment and warrants attention from existing shareholders.